Tourmaline Oil Corp. closed C$2.46 short of its 52-week high of C$69.25, which the company reached on May 23rd.

Tourmaline Oil Corp. closed C$1.88 short of its 52-week high of C$69.25, which the company reached on May 23rd.

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts ...

Barclays PLC increased its position in shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) by 283.7% in the 3rd ...

Pacibekitug is under clinical development by Tourmaline Bio and currently in Phase II for Graves' Ophthalmopathy.

CALGARY, AB, Dec. 11, 2024 /CNW/ - Tourmaline Oil Corp. (TSX: TOU) ("Tourmaline" or the "Selling Shareholder") and Topaz Energy Corp. (TSX: TPZ) ("Topaz" or the ...

Achieving full cycle profitability and efficiencies has allowed this energy stock to become a top dividend stock. The post ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Detailed price information for Tourmaline Bio Inc (TRML-Q) from The Globe and Mail including charting and trades.

You can sit under it while you get other things done, like checking emails or even just scrolling,” said TikToker Seth ...